抗坏血酸棕榈酸酯 × 修护

摘要中ascorbyl palmitate是多种纳米包裹成分之一，与咖啡因、白藜芦醇等联用，无法单独归因于ascorbyl palmitate的修护功效。

In the abstract, ascorbyl palmitate is one of multiple nanoencapsulated ingredients, combined with caffeine, resveratrol, etc., so the repair efficacy cannot be solely attributed to ascorbyl palmitate.

摘要中ascorbyl palmitate作为载体，与idebenone/naproxen联用，未单独验证其修护功效，且主要评价抗炎效果，非修护。

In the abstract, ascorbyl palmitate acts as a carrier, combined with idebenone/naproxen, without separate verification of its repair efficacy, and mainly evaluates anti-inflammatory effect, not repair.

摘要显示液晶配方有皮肤屏障增强效果（降低TEWL，增加水合），但未明确归因于ascorbyl palmitate，且主要关注递送和稳定性。

The abstract shows that the liquid crystal formulation has skin barrier enhancement effects (reduced TEWL, increased hydration), but does not clearly attribute to ascorbyl palmitate, and mainly focuses on delivery and stability.

摘要评估ascorbyl palmitate脂质体配方在角质层的渗透，未直接测试修护功效。

The abstract evaluates the penetration of ascorbyl palmitate liposomal formulation in the stratum corneum, without directly testing repair efficacy.

摘要提到ascorbyl palmitate通过抗氧化作用改善retinyl palmitate的皮肤分布，但未直接评估修护功效。

The abstract mentions that ascorbyl palmitate improves the skin distribution of retinyl palmitate through antioxidant action, but does not directly evaluate repair efficacy.

摘要主要评估ascorbyl palmitate纳米混悬液的皮肤递送和溶解性，未直接测试修护功效。

The abstract mainly evaluates the skin delivery and solubility of ascorbyl palmitate nanosuspensions, without directly testing repair efficacy.

摘要仅评估了ascorbyl palmitate/urea复合物的抗氧化和酪氨酸酶抑制活性，未涉及修护功效。

The abstract only evaluates the antioxidant and tyrosinase inhibitory activities of ascorbyl palmitate/urea complex, without involving repair efficacy.